Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma.
Munakata W, Shirasugi Y, Tobinai K, Onizuka M, Makita S, Suzuki R, Maruyama D, Kawai H, Izutsu K, Nakanishi T, Shiba S, Hojo S, Ando K.
Munakata W, et al. Among authors: shiba s.
Cancer Sci. 2021 Mar;112(3):1123-1131. doi: 10.1111/cas.14822. Epub 2021 Feb 15.
Cancer Sci. 2021.
PMID: 33492746
Free PMC article.
Clinical Trial.